Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand

Vaccine

Volumn 21, Issue 3-4, 2002, Pages 188-193

  Chunsuttiwat, Supamit ^a   Biggs, Beverley Ann ^b,c   Maynard, James E ^d   Thammapormpilas, Piyanit ^a   O Prasertsawat, Monthakarn ^e  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BURNET INSTITUTE   (Australia)

^d Prog Appropriate Technol Hlth   (United States)

^e Sawanpracharak Hospital   (Thailand)

Author keywords

DTP HB vaccine; Hepatitis B; Thailand

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; HUMAN; INFANT; NEWBORN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEROCONVERSION; THAILAND; VACCINATION; CHEMISTRY; COMPARATIVE STUDY; DRUG COMBINATION; ECONOMICS; EVALUATION; FEMALE; IMMUNOLOGY; MALE;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG THERAPY, COMBINATION; EVALUATION STUDIES; FEMALE; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; THAILAND; VACCINES, COMBINED;

EID: 0037073580     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00461-9     Document Type: Article

References (15)

1. World Health Organisation. Hepatitis B Vaccine Fact Sheet, July 2001. http://www.who.int/vaccines/intermediate/hepatitisb.htm.
2. Kane MA. Status of hepatitis B immunization programs in 1998. Vaccine 1998;16(Suppl):S104-8.
3. Global Alliance for Vaccines and Immunisation. Summary of Awards to 36 Countries from GAVI and the Vaccine Fund (After the Fourth Round of Proposal Reviews). http://www.vaccinealliance.org/reference/awards.html .
4. Chiu H.H., Huang L.M., Lee P.I., Safary A., Lee C.Y. Diphtheria, tetanus and whole cell pertussis vaccine combined with hepatitis B vaccines: a comparison of two doses (10 microg and 5 microg). Pediatr. Infect. Dis. J. 17(3):1998;206-211.
5. Diez-Delgado J., Dal-Re R., Llorente M., Gonzalez A., Lopez J. Hepatitis B component does not interfere with the immune response to diphtheria, tetanus, and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial of healthy infants. Vaccine. 15(12/13):1997;1418-1422.
6. Papaevangelou G. Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B vaccine administered to healthy infants according to a three-dose vaccination schedule. Vaccine. 13(2):1995;175-178.
7. Vryheid R.E., Kane M.A., Muller N., Schatz G.C., Bezabeh S. Infant and adolescent hepatitis B immunisation up to 1999: a global overview. Vaccine. 19:2000;1026-1037.
8. Papaevangelou G. Current combined vaccines with hepatitis B. Vaccine 1998;16(Suppl):S69-72.
9. Jacobs L. The right combination. Immunization Focus. May 2000. http://www.vaccinealliance.org/newsletter/may2000/briefing.html.
10. UNICEF, 2001. http://www.supply.unicef.dk/catalogue/.
11. Tanprasert S., Somjitta S. Trend study on HbsAg prevalence in Thai voluntary blood donors. Southeast Asian J. Trop. Med. Public Health. 24(Suppl 1):1993;43-45.
12. Poorvorawan Y., Theamboonlers A., Sanpavat S., Chumdermpadetsuk S., Safary A., Vandepapeliere P. Long-term antibody persistence after booster vaccination with combined tetravalent diphtheria, tetanus, whole-cell Bordetella pertussis and hepatitis vaccine in healthy infants. Ann. Trop. Paediatr. 17:1997;301-308.
13. Chunsuttiwat S., Biggs B.A., Maynard J.et al. Integration of hepatitis B immunization into the expanded program of immunization in Thailand. Vaccine. 15(6-7):1997;769-774.
14. Ministry of Public Health, EPI Coverage survey, 1999.
15. National Statistics Office, http://www.nso.go.th.